Regenerative Patch Technologies
PrivateLast Round
Grant
Jul 27, 2023
Total Funding Raised
$28.71M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Regenerative Patch Technologies is a biotechnology company that develops stem cell-based implant technology for the treatment of retinal diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Regenerative Patch Technologies Comparables
Compare Regenerative Patch Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Luxa Biotechnology | 90% | |
| Opsis Therapeutics | 84% | |
| Eyestem Research | 82% |
Regenerative Patch Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 27, 2023 | ||||
| Strategic | Apr 7, 2017 | ||||
| Grant | Mar 13, 2014 |
Regenerative Patch Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Marcus Foundation | Grant |
| California Institute for Regenerative Medicine | Grant |
| University of Southern California | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 12, 2026
Monthly visitors increased 57% MoM.
- Apr 16, 2026
Monthly visitors grew 60% MoM.
Regenerative Patch Technologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Regenerative Patch Technologies's valuation, stock price, and market status.
Is Regenerative Patch Technologies a public or private company?
Regenerative Patch Technologies is a private company.
What is the current stock price of Regenerative Patch Technologies?
Regenerative Patch Technologies is a private company with no public stock price. No recent secondary market data is available.
How much is Regenerative Patch Technologies worth (valuation)?
Valuation information for Regenerative Patch Technologies is not publicly available.
Can I buy Regenerative Patch Technologies stock?
Regenerative Patch Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Regenerative Patch Technologies's last funding round?
Regenerative Patch Technologies's most recent funding round was Grant on July 27, 2023.
Who are the main investors in Regenerative Patch Technologies?
Key investors in Regenerative Patch Technologies include California Institute for Regenerative Medicine.
Will Regenerative Patch Technologies IPO soon?
No public IPO plans have been announced for Regenerative Patch Technologies.
How can I track Regenerative Patch Technologies secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Regenerative Patch Technologies's secondary market activity and sign up for updates.